96 related articles for article (PubMed ID: 28919514)
1. HZ-6d targeted HERC5 to regulate p53 ISGylation in human hepatocellular carcinoma.
Wang Y; Ding Q; Xu T; Li CY; Zhou DD; Zhang L
Toxicol Appl Pharmacol; 2017 Nov; 334():180-191. PubMed ID: 28919514
[TBL] [Abstract][Full Text] [Related]
2. HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration.
Liu C; Li L; Hou G; Lu Y; Gao M; Zhang L
Life Sci; 2022 Aug; 303():120692. PubMed ID: 35671810
[TBL] [Abstract][Full Text] [Related]
3. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
4. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets.
Wong JJ; Pung YF; Sze NS; Chin KC
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10735-40. PubMed ID: 16815975
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Enzymes involved in ISGylation and Ubiquitination in patients with hepatocellular carcinoma.
Tong HV; Hoan NX; Binh MT; Quyen DT; Meyer CG; Hang DTT; Hang DTD; Son HA; Van Luong H; Thuan ND; Giang NT; Quyet D; Bang MH; Song LH; Velavan TP; Toan NL
Int J Med Sci; 2020; 17(3):347-353. PubMed ID: 32132870
[No Abstract] [Full Text] [Related]
6. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
Fornari F; Milazzo M; Galassi M; Callegari E; Veronese A; Miyaaki H; Sabbioni S; Mantovani V; Marasco E; Chieco P; Negrini M; Bolondi L; Gramantieri L
Mol Cancer Res; 2014 Feb; 12(2):203-16. PubMed ID: 24324033
[TBL] [Abstract][Full Text] [Related]
7. AZD3759 induces apoptosis in hepatoma cells by activating a p53-SMAD4 positive feedback loop.
Chao D; Pang L; Shi Y; Wang W; Liu K
Biochem Biophys Res Commun; 2019 Feb; 509(2):535-540. PubMed ID: 30598263
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
[TBL] [Abstract][Full Text] [Related]
10. CP-31398 inhibits the growth of p53-mutated liver cancer cells in vitro and in vivo.
He XX; Zhang YN; Yan JW; Yan JJ; Wu Q; Song YH
Tumour Biol; 2016 Jan; 37(1):807-15. PubMed ID: 26250460
[TBL] [Abstract][Full Text] [Related]
11. Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway.
Liu W; Li X; Chu ES; Go MY; Xu L; Zhao G; Li L; Dai N; Si J; Tao Q; Sung JJ; Yu J
Hepatology; 2011 Mar; 53(3):843-53. PubMed ID: 21319196
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression.
Kwon S; Jeon JS; Ahn C; Sung JS; Choi I
Biochem Biophys Res Commun; 2016 Oct; 479(1):74-9. PubMed ID: 27616194
[TBL] [Abstract][Full Text] [Related]
13. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG
J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504
[TBL] [Abstract][Full Text] [Related]
14. LincRNA-ROR/miR-145/ZEB2 regulates liver fibrosis by modulating HERC5-mediated p53 ISGylation.
Shen J; Wang Z; Liu M; Zhu YJ; Zheng L; Wang LL; Cheng JL; Liu TT; Zhang GD; Yang TY; Wang X; Zhang L
FASEB J; 2023 Jun; 37(6):e22936. PubMed ID: 37144417
[TBL] [Abstract][Full Text] [Related]
15. Transfection of Smac sensitizes tumor cells to etoposide-induced apoptosis and eradicates established human hepatoma in vivo.
Zhao J; Jin J; Zhang X; Shi M; Dai J; Wu M; Wang R; Guo Y
Cancer Gene Ther; 2006 Apr; 13(4):420-7. PubMed ID: 16211087
[TBL] [Abstract][Full Text] [Related]
16. Identification and Herc5-mediated ISGylation of novel target proteins.
Takeuchi T; Inoue S; Yokosawa H
Biochem Biophys Res Commun; 2006 Sep; 348(2):473-7. PubMed ID: 16884686
[TBL] [Abstract][Full Text] [Related]
17. Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro.
Lai PB; Chi TY; Chen GG
Apoptosis; 2007 Feb; 12(2):387-93. PubMed ID: 17191126
[TBL] [Abstract][Full Text] [Related]
18. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
Lu WJ; Chua MS; So SK
Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
[TBL] [Abstract][Full Text] [Related]
19. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
[TBL] [Abstract][Full Text] [Related]
20. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner.
Zhu Z; Luo Z; Li Y; Ni C; Li H; Zhu M
Hepatology; 2009 Feb; 49(2):504-12. PubMed ID: 19085961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
